Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma. (December 2016) - Hauck, S.; Khageh Hosseini, S.; Wesely, J.; Trojan, J.; Gerlach, K.; Schulze, J.; Hahn, S.; Steinhilber, D.; Gatterdam, V.; Zeuzem, S.; Waidmann, O.; Zangos, S.; et al.